Sensus Healthcare, Inc. (Nasdaq: SRTS) announced the launch of Sensus Healthcare Financial Services, a program aimed at helping dermatology practices acquire its SRT and IG-SRT systems through a streamlined process and flexible financing structures. The company said the platform is intended to improve conversion of purchase-oriented prospects by reducing administrative and financing barriers, complement its commercial strategy across independent practices and corporate accounts, and support a scalable go-to-market strategy as demand accelerates under a new reimbursement environment. The company also cited reimbursement clarity, including an approximate 300% increase in the per-fraction delivery code, and said financing options may include fair market value leasing and other tailored solutions through a bank-supported program administered in partnership with Sensus.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensus Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260218813528) on February 18, 2026, and is solely responsible for the information contained therein.